Hikma Pharmaceuticals Financial Overview
Hikma Pharmaceuticals's market cap is currently £3.89B. The company's EPS TTM is p0.9233994682; its P/E ratio is 13.61; and it has a dividend yield of 4.15%. Hikma Pharmaceuticals is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is p0.81. See an overview of income statement, balance sheet, and cash flow financials.
